Kostas Biliouris

Stock Analyst at BMO Capital

(0.82)
# 3,747
Out of 4,854 analysts
55
Total ratings
27.66%
Success rate
-22.21%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Kostas Biliouris

Rocket Pharmaceuticals
May 28, 2025
Maintains: Outperform
Price Target: $30$8
Current: $2.77
Upside: +188.81%
Avidity Biosciences
Mar 12, 2025
Initiates: Outperform
Price Target: $72
Current: $35.59
Upside: +102.30%
Dyne Therapeutics
Mar 12, 2025
Initiates: Outperform
Price Target: $50
Current: $13.99
Upside: +257.40%
Silence Therapeutics
Mar 4, 2025
Maintains: Outperform
Price Target: $67$25
Current: $5.41
Upside: +362.11%
Ionis Pharmaceuticals
Feb 20, 2025
Maintains: Market Perform
Price Target: $60$45
Current: $35.24
Upside: +27.70%
Intellia Therapeutics
Jan 10, 2025
Maintains: Outperform
Price Target: $70$50
Current: $7.58
Upside: +559.63%
Precision BioSciences
Jan 10, 2025
Upgrades: Outperform
Price Target: $34
Current: $5.18
Upside: +556.37%
Centessa Pharmaceuticals
Sep 16, 2024
Maintains: Outperform
Price Target: $20$35
Current: $11.86
Upside: +195.11%
Metagenomi
Aug 15, 2024
Maintains: Outperform
Price Target: $22$17
Current: $1.66
Upside: +924.10%
4D Molecular Therapeutics
Jul 18, 2024
Maintains: Outperform
Price Target: $63$40
Current: $3.91
Upside: +923.02%
Maintains: Outperform
Price Target: $90
Current: $31.48
Upside: +185.90%
Maintains: Outperform
Price Target: $234
Current: $308.00
Upside: -24.03%
Maintains: Outperform
Price Target: $170$200
Current: $39.21
Upside: +410.07%
Maintains: Outperform
Price Target: $120
Current: $12.48
Upside: +861.54%
Maintains: Outperform
Price Target: $57
Current: $17.00
Upside: +235.29%
Initiates: Market Perform
Price Target: $37
Current: $38.34
Upside: -3.50%
Maintains: Outperform
Price Target: $102$100
Current: $55.27
Upside: +80.93%
Initiates: Outperform
Price Target: $19
Current: $1.36
Upside: +1,297.06%
Maintains: Outperform
Price Target: $48$62
Current: $5.73
Upside: +982.02%
Initiates: Outperform
Price Target: $98
Current: $38.57
Upside: +154.08%